 Visit the TF Network Sites · Institutional Investor Center · Individual Investor Center |
| Download Plug-In |
| Real
Player 8 Basic Windows Media Player |
| Other Conference Calls |
| Other Feb 12 Calls Today's Calls |
| Call Details | |||
| Quidel Corporation Earnings Conference Call (Q4 2012) Scheduled to start Tue, Feb 12, 2013, 5:00 pm Eastern -- this event is ongoing now--
| |||
| About Quidel Corp (NasdaqGS:QDEL) | Other Calls | ||
| Quidel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of diagnostic testing solutions for applications primarily in infectious diseases, and reproductive and women’s health. It provides point-of-care and other diagnostic tests under the QuickVue, QuickVue+, Quidel, and MicroVue brand names. The company offers products for infectious diseases, such as Influenza, Group A Strep, and Respiratory Syncitial Virus test; and for reproductive and women's health, including pregnancy, Chlamydia trachomatis, and Bone Health. It also provides Immunoassay fecal occult blood test used to detect the presence of blood in stool specimens; and Helicobacter pylori test, a serological test to measure antibodies circulating in the blood caused by the immune response to the H. pylori bacterium. In addition, the company offers veterinary products; and clinical laboratory and research tests that are used in the measurement of circulating immune complexes, complement deficiencies, and complement activation. Quidel Corporation sells its products to professionals for use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, and wellness screening centers through a network of national and regional distributors, and a direct sales force in the United States, as well as through distributor arrangements primarily in Japan, Europe, and the Middle East. The company was founded in 1979 and is based in San Diego, California. | |||
More Info: | |||
